YOLFTbeta
Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler Strahlen- und Medizintechnik AG

EUZ · XETRA · Healthcare / Medical Devices

15.34EUR+0.84 (+5.79%)

Price History

Full chart

Market Stats

Previous Close14.50
Open14.50
Day Range14.39 – 15.71
52-Week Range12.01 – 17.65
Volume319.50K
Market Cap772.82M
P/E (TTM)15.44
Forward P/E15.04
EPS0.80
Dividend Yield1.78%
Beta1.47
50-Day Avg13.01
200-Day Avg14.60

About

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Harald Hasselmann
  • Employees1.10K
  • HeadquartersRobert-Rössle-Straße 10, Berlin, Germany, 13125, Germany
  • Websitehttps://www.ezag.com

Leadership

  • Dr. Harald HasselmannCEO & Chairman of the Executive Board of Medical Segment · b. 1967
  • Dr. Gunnar MannCOO & Member of the Executive Board · b. 1967
  • Ms. Karolin RiehleHead of Investor Relations & PR
  • Mr. Joseph HathcockChief Operating Officer of Segment Isotope Products
  • Ivan SimmerManaging Director of Eckert & Ziegler Cesio s.r.o.
  • Mr. Julian SchröderHead of Group Controlling

Financials

Income Statement

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue31.22M29.20M35.53M41.79M50.38M54.44M71.61M101.40M111.09M116.20M120.00M117.14M127.26M140.05M137.94M138.63M168.71M178.49M176.14M180.44M222.26M246.09M295.85M311.96M
Growth (%)--6.47%+21.68%+17.61%+20.54%+8.07%+31.53%+41.59%+9.56%+4.59%+3.27%-2.38%+8.64%+10.05%-1.51%+0.50%+21.70%+5.80%-1.32%+2.44%+23.18%+10.72%+20.22%+5.45%
Cost of Revenue15.96M15.74M19.23M23.30M-23.90M27.58M37.45M50.27M53.30M51.78M54.81M60.06M63.47M76.88M71.81M74.77M94.36M91.47M89.61M94.01M115.48M129.75M152.69M164.75M
Gross Profit15.27M13.46M16.31M18.49M21.94M26.86M34.16M51.12M57.80M64.41M65.18M57.08M63.78M62.35M66.12M63.87M74.35M87.02M86.53M91.08M106.78M116.34M143.16M147.21M
Gross Margin48.90%46.08%45.89%44.25%43.56%49.34%47.70%50.42%52.03%55.43%54.32%48.72%50.12%44.52%47.94%46.07%44.07%48.75%49.13%50.48%48.04%47.28%48.39%47.19%
Operating Expense13.27M9.72M12.86M15.96M16.07M20.89M24.69M35.66M39.48M41.57M45.25M44.18M51.47M44.65M50.88M44.68M51.16M55.40M51.29M45.05M59.81M69.35M82.08M72.16M
Operating Income1.99M3.73M3.45M2.54M5.88M5.97M9.47M15.46M18.32M22.84M19.93M12.90M12.31M17.70M15.24M19.19M23.19M31.63M35.24M46.03M46.97M47.00M61.07M75.06M
Operating Margin6.38%12.78%9.71%6.07%11.67%10.97%13.22%15.25%16.49%19.66%16.61%11.01%9.68%12.64%11.05%13.84%13.74%17.72%20.01%25.51%21.13%19.10%20.64%24.06%
EBITDA6.25M7.42M7.31M6.45M10.15M9.48M18.69M28.01M26.71M30.63M28.00M22.65M20.57M27.14M25.32M26.87M31.95M39.45M43.05M56.68M57.90M59.67M77.38M92.13M
EBITDA Margin20.03%25.40%20.57%15.43%20.16%17.42%26.10%27.62%24.04%26.36%23.33%19.33%16.16%19.38%18.36%19.38%18.94%22.10%24.44%31.41%26.05%24.25%26.15%29.53%
Net Income346.00K-1.17M3.35M1.59M-2.15M3.04M21.89M10.41M10.42M10.29M9.09M6.78M10.72M9.55M14.70M16.13M22.02M21.29M34.53M29.28M26.30M33.28M48.76M
Net Income Margin1.11%-4.02%9.42%3.80%-3.95%4.24%21.59%9.38%8.97%8.58%7.76%5.32%7.65%6.92%10.60%9.56%12.34%12.09%19.14%13.17%10.69%11.25%15.63%
R&D3.43M670.00K350.00K512.00K215.00K134.00K3.11M2.50M2.89M3.00M3.45M3.64M3.29M3.65M3.11M3.32M3.81M3.75M3.38M3.78M4.29M4.33M4.86M5.10M
R&D as % of Total Revenue10.98%2.29%0.98%1.23%0.43%0.25%4.34%2.46%2.60%2.58%2.88%3.10%2.59%2.60%2.25%2.40%2.26%2.10%1.92%2.10%1.93%1.76%1.64%1.64%
Interest Expense176.00K236.00K359.00K716.00K0830.00K1.24M1.33M2.52M2.89M2.79M1.19M1.63M1.44M1.16M881.00K672.00K1.09M1.19M1.20M1.77M3.99M3.75M1.94M
Interest Expense % of Total Revenue0.56%0.81%1.01%1.71%0.00%1.52%1.73%1.31%2.27%2.49%2.33%1.01%1.28%1.03%0.84%0.64%0.40%0.61%0.68%0.66%0.80%1.62%1.27%0.62%

Balance Sheet

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets49.73M45.71M48.96M67.00M64.17M67.59M98.80M161.90M144.47M154.04M164.44M178.91M187.33M196.68M199.47M216.99M229.05M274.24M292.00M347.73M416.84M439.36M442.40M485.68M
Total Liabilities16.80M16.89M16.31M32.04M28.27M31.45M55.98M75.25M70.86M72.47M77.47M88.28M92.84M92.01M89.39M99.47M105.17M134.79M143.08M155.20M203.21M215.27M217.18M232.25M
Total Equity32.93M28.81M32.65M34.76M35.91M36.14M42.82M76.41M68.31M75.88M80.73M83.55M88.58M99.69M105.19M112.34M122.64M138.19M147.82M187.39M212.07M222.18M223.45M251.77M
Cash6.14M8.94M5.50M4.95M4.68M4.38M7.31M43.67M29.22M32.30M30.84M29.41M21.82M31.47M36.57M57.71M54.19M78.92M87.47M93.66M82.70M68.00M118.22M128.69M
Total Debt4.00M4.29M2.58M12.75M--18.51M20.07M31.92M23.30M15.45M22.63M18.70M15.53M11.66M1.73M42.00K19.89M20.40M26.97M49.59M56.30M55.34M44.80M
Net Debt-2.13M-4.65M-2.92M7.80M-4.68M-4.38M11.20M-23.60M2.70M-9.01M-15.40M-6.79M-3.12M-15.94M-24.91M-55.97M-54.14M-59.04M-67.07M-66.69M-33.11M-11.69M-62.88M-83.88M

Cash Flow

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.01M4.15M2.56M3.53M6.92M8.29M8.57M22.11M15.03M20.16M16.57M14.65M10.65M16.23M19.83M26.83M21.21M40.43M36.79M33.85M34.30M46.95M66.57M60.41M
Investing Cash Flow-3.80M347.00K-5.72M-4.32M-2.67M-4.58M-5.46M-9.70M-7.54M-8.85M-11.35M-17.37M-10.81M972.00K-5.53M5.11M-10.70M-5.65M-13.35M-23.59M-41.04M-42.74M-16.59M-25.93M
Financing Cash Flow-1.45M-1.63M-251.00K25.00K-1.95M-2.20M-254.00K23.99M-22.28M-8.41M-6.59M1.68M-8.55M-8.42M-9.52M-9.96M-14.60M-10.50M-12.96M-6.06M-5.71M-9.28M-9.99M-21.53M
Capital Expenditure2.70M1.53M3.23M3.68M005.98M5.69M5.78M9.18M9.83M9.65M7.82M3.84M5.33M4.16M6.12M7.25M8.90M28.86M31.13M26.28M17.19M26.02M
Free Cash Flow4.31M2.62M-672.00K-146.00K6.92M8.29M2.58M16.42M9.25M10.98M6.74M5.00M2.84M12.39M14.50M22.67M15.09M33.17M27.88M5.00M3.17M21.12M49.38M34.39M
Dividends Paid1.46M--775.00K--786.00K1.13M2.33M3.17M3.17M3.17M3.17M3.17M3.17M3.49M4.13M6.18M8.75M9.32M10.38M10.41M1.04M10.43M
FCF to OCF61.48%63.07%-26.26%-4.13%100.00%100.00%30.14%74.25%61.54%54.45%40.68%34.13%26.64%76.32%73.11%84.49%71.13%82.06%75.79%14.77%9.24%44.99%74.17%56.92%
Dividend Paid to FCF33.90%---530.82%--30.44%6.89%25.25%28.91%47.06%63.47%111.80%25.62%21.88%15.40%27.38%18.62%31.39%186.46%327.71%49.27%2.11%30.33%

Earnings

Report DateJun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008May 5, 2009Aug 4, 2009Nov 3, 2009Mar 30, 2010May 4, 2010Aug 3, 2010Nov 2, 2010Mar 30, 2011May 3, 2011Aug 2, 2011Nov 2, 2011Mar 30, 2012May 3, 2012Aug 14, 2012Nov 6, 2012Mar 28, 2013Aug 15, 2013Nov 8, 2013Mar 27, 2014May 6, 2014Aug 5, 2014Nov 6, 2014Mar 26, 2015May 5, 2015Aug 4, 2015Nov 5, 2015Mar 23, 2016May 10, 2016Aug 2, 2016Nov 3, 2016Mar 23, 2017May 9, 2017Aug 2, 2017Nov 9, 2017Mar 22, 2018May 8, 2018Jul 31, 2018Nov 13, 2018Apr 5, 2019Aug 13, 2019Nov 12, 2019Mar 31, 2020May 12, 2020Aug 13, 2020Nov 10, 2020Mar 30, 2021May 11, 2021Aug 12, 2021Nov 9, 2021Mar 30, 2022May 12, 2022Aug 11, 2022Nov 14, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Oct 17, 2023Mar 22, 2024May 14, 2024Aug 9, 2024Nov 14, 2024Mar 27, 2025May 13, 2025Aug 8, 2025Nov 13, 2025Mar 26, 2026May 12, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate-----------------------------0.020.03-0.040.030.04-0.060.060.05-0.060.040.03-0.040.05----0.02---0.03-----------0.62-1.110.72----------------0.45----------
EPS Actual0.040.020.000.00-0.020.010.010.020.010.030.000.010.010.010.000.010.020.020.020.000.020.02-0.000.020.190.030.04-0.150.050.040.030.170.040.040.040.030.060.050.040.030.040.050.030.050.040.040.130.080.080.110.020.040.080.020.030.040.030.130.090.690.540.490.470.030.090.890.611.411.110.630.980.370.240.250.670.410.340.250.320.420.380.290.230.300.450.290.410.460.260.470.460.560.130.300.170.19-
Surprise-----------------------------100.00%0.00%-0.00%33.33%0.00%-0.00%-16.67%-20.00%--33.33%25.00%0.00%-0.00%-20.00%----0.00%---0.00%------------1.61%-0.00%-12.50%-----------------9.51%----------
Timing-----------------------------Pre-marketPre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-market-After-hoursPre-market----After-hours---Pre-market----------------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap772.82M
Enterprise Value1.06B
Trailing P/E15.44
Forward P/E15.04
PEG Ratio0.91
Price / Sales2.47
Price / Book5.01
EPS0.80
Book Value4.30
Revenue (TTM)312.50M
Gross Profit (TTM)152.24M
EBITDA88.66M
Profit Margin15.92%
Operating Margin22.71%
Return on Equity20.14%
Return on Assets10.30%
Shares Outstanding62.58M
Shares Float42.79M
Beta1.47
Dividend Yield1.78%
Dividend Rate0.22
Payout Ratio27.80%

Dividends

20261×
0.22Jun 25, 2026
20251×
0.17Jun 19, 2025
20242×
0.02Jun 27, 20240.50May 29, 2024
20231×
0.17Jun 8, 2023
20221×
0.17Jun 2, 2022
20211×
0.15Jun 3, 2021
20202×
1.70Jun 18, 20200.14Jun 11, 2020
20191×
0.10May 30, 2019
20181×
0.07May 31, 2018
20171×
0.06Jun 1, 2017
20161×
0.05Jun 9, 2016
20151×
0.05Jun 4, 2015
20141×
0.05May 23, 2014
20131×
0.05May 20, 2013
20121×
0.05May 25, 2012
20111×
0.05May 20, 2011
20101×
0.04May 21, 2010
20091×
0.03May 21, 2009
20081×
0.02Jun 12, 2008
20071×
0.02Jun 13, 2007
20061×
0.01May 31, 2006
20051×
0.02Jun 1, 2005

Stock Splits

  • Aug 13, 20253:1
  • Jul 31, 20204:1